ScoreData announced that it has signed a multi-year agreement with NTT DATA Services, a global digital business, and IT Services leader, to deploy its nudge engines along with NTT DATA’s Artificial Intelligence (AI) solution that predicts risk for early onset of chronic diseases for health insurance and provider communities.
Recommended AI News: Machine Learning Removes Bias From Algorithms and the Hiring Process
In extensive tests using publicly available CDC and other medical data sets, ScoreFast Predictive SmartConnect Nudge Engines for prescriptions adherence, exercise and diet demonstrated a 12% reduction in readmission rates and a 15% reduction in claims filed. By integrating the Predictive SmartConnect Nudge Engines with NTT DATA’s AI Solution, healthcare providers can make early disease predictions and provide quicker and more efficient intervention measure to better manage chronic conditions, which further reduces hospital admissions and readmissions, as well as helping at-risk patients prevent or delay the onset of chronic conditions.
Recommended AI News: Verimatrix Launches New Brand Campaign: Security Made for People
“We can save money and improve quality of life by applying our AI solution to make early predictions of patients at risk of certain chronic diseases and then using ScoreData’s Nudge Engines to deliver evidence-based health recommendations,” said Tanvir Khan, Executive Vice President, Dynamic Workplace Services and Business Process Outsourcing, NTT DATA Services. “For example, if we predict a patient at risk for diabetes, then we can use Nudge Engines to send health reminders and help monitor the eyes for early symptoms of diabetic retinopathy,” he added.
“Patient journeys in the health management ecosystem can be significantly improved by AI-powered interactions and nudges, from the time of patient discharge to recuperation, and claims filing. With a deep understanding of a disease, treatment options, a patient’s social environment, and lifestyles, ScoreData can significantly improve system efficiencies and patient health” said Dr. Jane Lombard Medical Director of the Women’s Health programs at El Camino Health Group in Palo Alto, California.
Recommended AI News: iSIZE Announces Strategic Partnership With Intel